Fingerprint
Dive into the research topics of 'Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically